Thin Film Drug Manufacturing Market Report 2026

Thin Film Drug Manufacturing Market Overview

• Thin Film Drug Manufacturing market size has reached to $8.71 billion in 2025 • Expected to grow to $13.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Growing Elderly Population Boosts Demand For Thin-Film Drug Manufacturing Solutions • Market Trend: Thin Film Drug Innovations Enhance Compliance And Effectiveness • North America was the largest region in 2025.

What Is Covered Under Thin Film Drug Manufacturing Market?

Thin film drug manufacturing involves creating pharmaceutical products in the form of thin, flexible films that dissolve quickly when placed in the mouth. This method enhances drug absorption and patient compliance by providing a convenient and effective delivery system. It is often used for medications requiring a rapid onset of action or those that are difficult to swallow. The main types of thin film drug manufacturing are oral thin film, transdermal film, and other types. Oral thin film is a type of drug delivery system that dissolves on the tongue or inside the mouth, providing rapid absorption of medication for conditions such as nausea, pain, or mental health disorders. These films are utilized for various disease indications, including schizophrenia, migraine, opioid dependence, nausea and vomiting, and others, and are distributed through multiple channels, such as hospital pharmacies, drug stores, retail pharmacies, and e-commerce.

What Is The Thin Film Drug Manufacturing Market Growth Forecast?

The thin film drug manufacturing market size is expected to see strong growth in the next few years. It will grow to $13.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in thin film formulation technologies, growing prevalence of neurological disorders, expansion of e-commerce pharmaceutical distribution, increasing investment in novel drug delivery systems, rising regulatory approvals for thin film drugs. Major trends in the forecast period include rising adoption of oral thin films for rapid drug delivery, increasing demand for patient-friendly dosage forms, growth in use of thin films for neurological and cns disorders, expansion of taste-masked and orodispersible film technologies, rising application of thin films in migraine and opioid dependence treatment.

Global Thin Film Drug Manufacturing Market Segmentation

1) By Type: Oral Thin Film, Transdermal Film, Other Types 2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications 3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce Subsegments: 1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films 2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films 3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films

What Is The Driver Of The Thin Film Drug Manufacturing Market?

The increase in the global elderly population is expected to propel the growth of the thin-film drug manufacturing market going forward. The rise in the global elderly population is influenced by extended life expectancies, medical advancements, improved nutrition and healthcare, and changes in family structures and societal norms. Thin film drug manufacturing helps meet the needs of the growing elderly population by offering improved medication adherence, ease of use, precise dosage control, rapid dissolution, and enhanced stability, which together supports better management of chronic conditions and overall health in older adults. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Therefore, the increase in the global elderly population is driving the thin film drug manufacturing industry.

Key Players In The Global Thin Film Drug Manufacturing Market

Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy's Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.

Global Thin Film Drug Manufacturing Market Trends and Insights

Major companies operating in the thin film drug manufacturing market are focusing on developing innovative products, such as oral thin film technologies, to enhance patient compliance and ease of use. Oral thin film technologies involve creating rapidly dissolving films that deliver medication through the mucous membranes in the mouth for quick absorption. These films offer a convenient, effective, and user-friendly alternative to traditional oral dosage forms such as tablets and capsules. For instance, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, announced the Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of acute migraine. This new formulation allows for rapid dissolution and absorption, potentially providing faster relief for migraines compared to traditional tablets. This innovation enhances bioavailability and offers a more convenient, user-friendly option, improving patient compliance. The thin film technology enhances patient compliance and ease of use, making it a more user-friendly alternative for managing acute migraine attacks.

What Are Latest Mergers And Acquisitions In The Thin Film Drug Manufacturing Market?

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. for an undisclosed amount. With this acquisition, DifGen aims to enhance its manufacturing capabilities to offer complex dosage forms, ensure a reliable local supply, and provide patients with affordable, high-quality, and consistently available lifesaving medications. Aveva Drug Delivery Services Inc. is a US-based developer and manufacturer of transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Regional Insights

North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thin Film Drug Manufacturing Market?

The thin film drug manufacturing market consists of sales of buccal films, sublingual films, intranasal films, and topical films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thin Film Drug Manufacturing Market Report 2026?

The thin film drug manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thin film drug manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.